(Total Views: 568)
Posted On: 10/30/2024 8:53:16 AM
Post# of 153875
Sounds like word is about to spread from a very reliable and respected source.
Quote:
Dr. Palmer added, “This is an exciting time in liver health research, as scientific innovation paves the way for improved treatments for conditions like MASH and liver fibrosis. I look forward to collaborating with the CytoDyn team to advance clinical evaluations of leronlimab, including the studies in motion, and explore new treatments that have the potential to truly transform patient outcomes."
(14)
(0)
My comments are just my opinions and should NOT be taken as investment advice.
